OL
BSX icon

Optas LLC’s Boston Scientific BSX Stock Holding History

Optas LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,366
Closed -$274K – 502
2026
Q1 		$274K Sell
4,366
-1,252
-22% -$100K 0.04% 339
2025
Q4 		$536K Buy
5,618
+1,204
+27% +$118K 0.08% 161
2025
Q3 		$431K Buy
4,414
+673
+18% +$69.7K 0.07% 182
2025
Q2 		$402K Sell
3,741
-186
-5% -$18.8K 0.08% 170
2025
Q1 		$396K Buy
3,927
+49
+1% +$4.93K 0.07% 148
2024
Q4 		$346K Buy
3,878
+327
+9% +$28.8K 0.07% 156
2024
Q3 		$298K Buy
3,551
+670
+23% +$52.8K 0.07% 173
2024
Q2 		$222K Buy
+2,881
New +$211K 0.06% 187

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Optas LLC's BSX Position: Q2 2026 in Review

Optas LLC sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,366 shares — an estimated $274K sold.

Optas LLC first reported a position in BSX in Q2 2024 and held it in 8 quarters. The position peaked at $536K in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Optas LLC reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Optas LLC sold 4,366 Boston Scientific shares in Q2 2026, an estimated $274K.
  • Optas LLC first reported a position in Boston Scientific in Q2 2024 and held it in 8 quarters.
  • Optas LLC's Boston Scientific position peaked at $536K in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.